Northern Trust Corp Xencor Inc Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Xencor Inc stock. As of the latest transaction made, Northern Trust Corp holds 626,497 shares of XNCR stock, worth $14.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
626,497
Previous 664,109 5.66%
Holding current value
$14.5 Million
Previous $12.6 Million 0.21%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$15.7 - $21.65 $590,508 - $814,299
-37,612 Reduced 5.66%
626,497 $12.6 Million
Q2 2024

Aug 14, 2024
SELL
$18.21 - $24.5 $367,386 - $494,287
-20,175 Reduced 2.95%
664,109 $12.6 Million
Q1 2024

May 14, 2024
SELL
$18.65 - $26.52 $645,942 - $918,520
-34,635 Reduced 4.82%
684,284 $15.1 Million
Q4 2023

Feb 13, 2024
BUY
$16.53 - $21.42 $737,651 - $955,867
44,625 Added 6.62%
718,919 $15.3 Million
Q3 2023

Nov 13, 2023
SELL
$20.08 - $25.39 $1.39 Million - $1.76 Million
-69,327 Reduced 9.32%
674,294 $13.6 Million
Q2 2023

Aug 11, 2023
BUY
$24.77 - $29.9 $539,639 - $651,401
21,786 Added 3.02%
743,621 $18.6 Million
Q1 2023

May 15, 2023
SELL
$25.95 - $36.95 $223,559 - $318,324
-8,615 Reduced 1.18%
721,835 $20.1 Million
Q4 2022

Feb 13, 2023
BUY
$24.79 - $30.86 $633,235 - $788,287
25,544 Added 3.62%
730,450 $19 Million
Q3 2022

Nov 14, 2022
BUY
$24.62 - $32.44 $327,175 - $431,095
13,289 Added 1.92%
704,906 $18.3 Million
Q2 2022

Aug 12, 2022
BUY
$19.74 - $29.01 $1.72 Million - $2.53 Million
87,333 Added 14.45%
691,617 $18.9 Million
Q1 2022

May 13, 2022
SELL
$26.68 - $41.63 $196,364 - $306,396
-7,360 Reduced 1.2%
604,284 $16.1 Million
Q4 2021

Feb 08, 2022
SELL
$33.67 - $43.44 $1.09 Million - $1.4 Million
-32,287 Reduced 5.01%
611,644 $24.5 Million
Q3 2021

Nov 15, 2021
BUY
$30.65 - $35.68 $80,824 - $94,088
2,637 Added 0.41%
643,931 $21 Million
Q2 2021

Aug 13, 2021
SELL
$34.33 - $44.68 $1.38 Million - $1.8 Million
-40,248 Reduced 5.91%
641,294 $22.1 Million
Q1 2021

May 12, 2021
SELL
$40.81 - $53.88 $607,742 - $802,380
-14,892 Reduced 2.14%
681,542 $29.3 Million
Q4 2020

Feb 11, 2021
SELL
$36.63 - $47.63 $1.65 Million - $2.15 Million
-45,129 Reduced 6.09%
696,434 $30.4 Million
Q3 2020

Nov 16, 2020
SELL
$30.09 - $43.02 $738,107 - $1.06 Million
-24,530 Reduced 3.2%
741,563 $28.8 Million
Q2 2020

Aug 14, 2020
BUY
$27.76 - $33.42 $3.17 Million - $3.81 Million
114,032 Added 17.49%
766,093 $24.8 Million
Q1 2020

May 14, 2020
BUY
$20.69 - $37.79 $159,913 - $292,078
7,729 Added 1.2%
652,061 $19.5 Million
Q4 2019

Feb 14, 2020
SELL
$32.75 - $41.43 $27,346 - $34,594
-835 Reduced 0.13%
644,332 $22.2 Million
Q3 2019

Nov 13, 2019
BUY
$33.73 - $46.27 $1.13 Million - $1.54 Million
33,370 Added 5.45%
645,167 $21.8 Million
Q2 2019

Aug 13, 2019
BUY
$29.6 - $40.93 $171,561 - $237,230
5,796 Added 0.96%
611,797 $25 Million
Q1 2019

May 13, 2019
BUY
$27.85 - $38.09 $58,039 - $79,379
2,084 Added 0.35%
606,001 $18.8 Million
Q4 2018

Feb 12, 2019
BUY
$32.39 - $42.05 $56,714 - $73,629
1,751 Added 0.29%
603,917 $21.8 Million
Q3 2018

Nov 14, 2018
BUY
$35.69 - $47.65 $500,052 - $667,624
14,011 Added 2.38%
602,166 $23.5 Million
Q2 2018

Sep 18, 2018
SELL
$28.41 - $42.41 $86,394 - $128,968
-3,041 Reduced 0.51%
588,155 $21.8 Million
Q2 2018

Aug 14, 2018
BUY
$28.41 - $42.41 $3.13 Million - $4.67 Million
110,169 Added 22.9%
591,196 $21.9 Million
Q1 2018

May 09, 2018
BUY
$21.18 - $33.78 $89,083 - $142,078
4,206 Added 0.88%
481,027 $14.4 Million
Q4 2017

Feb 14, 2018
SELL
$19.29 - $24.83 $220,407 - $283,707
-11,426 Reduced 2.34%
476,821 $10.5 Million
Q3 2017

Nov 13, 2017
BUY
$19.61 - $23.35 $9.57 Million - $11.4 Million
488,247
488,247 $11.2 Million

Others Institutions Holding XNCR

# of Institutions
215
Shares Held
71.8M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.38B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email